Your browser doesn't support javascript.
loading
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma.
Reni, Michele; Peretti, Umberto; Zanon, Silvia; Macchini, Marina; Balzano, Gianpaolo; Mazza, Elena; Tamburrino, Domenico; Orsi, Giulia; Arcidiacono, Paolo Giorgio; Falconi, Massimo; Gianni, Luca.
Affiliation
  • Reni M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy. reni.michele@hsr.it.
  • Peretti U; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
  • Zanon S; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
  • Macchini M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
  • Balzano G; Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
  • Mazza E; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
  • Tamburrino D; Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
  • Orsi G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
  • Arcidiacono PG; Pancreato-Biliary Endoscopy and Endosonography Division, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
  • Falconi M; Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
  • Gianni L; Università "Vita E Salute", Via Olgettina 58, 20132, Milan, Italy.
Cancer Chemother Pharmacol ; 85(4): 641-650, 2020 04.
Article in En | MEDLINE | ID: mdl-32157412

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / CA-19-9 Antigen / Carcinoma, Pancreatic Ductal / Duration of Therapy Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2020 Type: Article Affiliation country: Italy

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / CA-19-9 Antigen / Carcinoma, Pancreatic Ductal / Duration of Therapy Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2020 Type: Article Affiliation country: Italy